Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Targeting FSP1 to induce ferroptosis in chromophobe renal cell carcinoma
Treatments at Vitadrip IV are all done by licensed nurses and clinicians in a medically supervised clinic in Edmonton
These studies aim to map potential mechanisms rather than confirm therapeutic outcomes
PMID: 24018645
Relative ratios of pyruvate to citrate metabolite levels of each indicated cell line from the metabolomics analysis in Figure 4E
US$ 25.06
US$ 24.72
US$ 20.73
US$ 27.83
US$ 21.10
US$ 24.70
US$ 28.03
US$ 24.10
US$ 22.09
US$ 22.47
